Eterna Therapeutics Inc. (ERNA)
USD 0.27
(3.13%)
USD 0.27
(3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.4 Million | -20.97 Million | -23.48 Million | -8.1 Million | 2.74 Million | 1.36 Million |
| Net Income | -21.66 Million | -24.57 Million | -122.3 Million | -7.29 Million | -2.04 Million | -259 Thousand |
| Depreciation & Amortization | 1.12 Million | 497 Thousand | 459 Thousand | 98 Thousand | 3.16 Million | 2.76 Million |
| Deferred income taxes | 2.89 Million | - | 9.35 Million | -19.24 Million | - | - |
| Stock-based compensation | 1.24 Million | 2.93 Million | 5.23 Million | 91 Thousand | - | - |
| Change in working capital | -2.11 Million | 3.71 Million | -2.35 Million | -999 Thousand | -37 Thousand | -2.26 Million |
| Other non-cash items | -1.88 Million | -3.53 Million | 86.12 Million | 19.24 Million | 7.23 Million | 6.91 Million |
| Investing Cash Flow | -19 Thousand | -47 Thousand | -22.74 Million | -39 Thousand | -1.06 Million | -1.57 Million |
| Investments in PPE | -19 Thousand | -297 Thousand | -154 Thousand | -39 Thousand | -1.09 Million | -1.61 Million |
| Acquisitions | - | 250 Thousand | -22.7 Million | - | 29 Thousand | 33 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 250 Thousand | 119 Thousand | - | - | - |
| Financing Cash Flow | 16.55 Million | 19.57 Million | 61.58 Million | 4.66 Million | -1.09 Million | -303 Thousand |
| Debt repayment | -16.25 Million | -2000.00 | -942 Thousand | -310 Thousand | -1.04 Million | -1.64 Million |
| Dividends payments | -16 Thousand | -16 Thousand | -8000.00 | - | -16 Thousand | -16 Thousand |
| Common Stock Repurchased | -16.25 Million | - | - | - | - | - |
| Common Stock Issuance | 320 Thousand | 19.7 Million | 62.53 Million | 4.35 Million | - | 1.37 Million |
| Other Financing Activities | 48.75 Million | -109 Thousand | - | 620 Thousand | -37 Thousand | -17 Thousand |
| Accounts receivables | 527 Thousand | -262 Thousand | -659 Thousand | 1.67 Million | -248 Thousand | -507 Thousand |
| Accounts payables | -2.89 Million | 2.03 Million | -485 Thousand | -1.73 Million | 669 Thousand | -186 Thousand |
| Inventory | - | 262 Thousand | 485 Thousand | 52 Thousand | 337 Thousand | 431 Thousand |
| Other working capital | 254 Thousand | 1.67 Million | -1.69 Million | -994 Thousand | -795 Thousand | -2 Million |
| Cash at beginning of period | 11.44 Million | 16.98 Million | 1.63 Million | 5.1 Million | 2.58 Million | 3.37 Million |
| Cash at end of period | 7.57 Million | 15.54 Million | 16.98 Million | 1.63 Million | 3.25 Million | 2.58 Million |
| Capital Expenditure | -19 Thousand | -297 Thousand | -154 Thousand | -39 Thousand | -1.09 Million | -1.61 Million |
| Effect of forex changes on cash | - | - | - | - | 92 Thousand | - |
| Net cash flow / Change in cash | -3.87 Million | -1.44 Million | 15.35 Million | -3.47 Million | 673 Thousand | -792 Thousand |
| Free Cash Flow | -20.42 Million | -21.27 Million | -23.64 Million | -8.14 Million | 1.65 Million | -247 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.52 Million | -6.64 Million | -21.66 Million | -6.15 Million | -5.59 Million | -4.5 Million |
| Depreciation & Amortization | 578 Thousand | 541 Thousand | 1.12 Million | 481 Thousand | 517 Thousand | 63 Thousand |
| Deferred income taxes | - | - | 2.89 Million | 210 Thousand | -20 Thousand | -190 Thousand |
| Stock-based compensation | 423 Thousand | 282 Thousand | 1.24 Million | 165 Thousand | 174 Thousand | 214 Thousand |
| Change in working capital | 1.75 Million | 980 Thousand | -2.11 Million | 355 Thousand | -958 Thousand | -34 Thousand |
| Other non-cash items | 885 Thousand | 1.92 Million | -1.88 Million | 281 Thousand | 52 Thousand | 583 Thousand |
| Investing Cash Flow | -249 Thousand | -97 Thousand | -19 Thousand | -19 Thousand | - | - |
| Investments in PPE | -249 Thousand | -101 Thousand | -19 Thousand | -19 Thousand | - | - |
| Acquisitions | - | 4000.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 4000.00 | - | - | - | - |
| Financing Cash Flow | -22 Thousand | 1.38 Million | 16.55 Million | 7.7 Million | 8.54 Million | 312 Thousand |
| Debt repayment | - | -1.4 Million | -16.25 Million | -7.71 Million | -8.54 Million | - |
| Dividends payments | -8000.00 | - | -16 Thousand | -8000.00 | - | -8000.00 |
| Common Stock Repurchased | - | - | -16.25 Million | - | - | - |
| Common Stock Issuance | - | - | 320 Thousand | - | - | 320 Thousand |
| Other Financing Activities | -14 Thousand | -20 Thousand | 48.75 Million | 15.42 Million | 17.08 Million | - |
| Accounts receivables | 123 Thousand | 74 Thousand | 527 Thousand | 1.35 Million | -792 Thousand | -337 Thousand |
| Accounts payables | 1.08 Million | 461 Thousand | -2.89 Million | -4.11 Million | 1.66 Million | 1.31 Million |
| Inventory | - | - | - | -825 Thousand | 792 Thousand | 337 Thousand |
| Other working capital | 541 Thousand | 445 Thousand | 254 Thousand | 3.93 Million | -2.62 Million | -1.34 Million |
| Cash at beginning of period | 5.11 Million | 7.57 Million | 11.44 Million | 4.55 Million | 5.93 Million | 9.49 Million |
| Cash at end of period | 2.58 Million | 5.11 Million | 7.57 Million | 7.57 Million | 8.64 Million | 5.93 Million |
| Capital Expenditure | -249 Thousand | -101 Thousand | -19 Thousand | -19 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.53 Million | -2.45 Million | -3.87 Million | 3.02 Million | 2.71 Million | -3.56 Million |
| Free Cash Flow | -2.5 Million | -3.84 Million | -20.42 Million | -4.68 Million | -5.82 Million | -3.87 Million |
SNA
ARBV
3202
WMNNF
RGBD
TRX